Sources | Names Used |
---|---|
CTRPv2 | JQ-1:vorinostat (2:1 mol/mol) |
PharmacoGx | JQ-1:vorinostat (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CTHRC1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | PIR | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | ZNF616 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | CFD | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | NOXO1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | AC131097.4 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | C9orf24 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | FNBP4 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | TAS2R60 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
mRNA | ATG9B | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |